Order Article Reprints

Okuno K, Xu C, Pascual-Sabater S, Tokunaga M, Takayama T, Han H, Fillat C, Kinugasa Y, Goel A. Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines. 2023; 11(1):119. https://doi.org/10.3390/biomedicines11010119

Okuno, Keisuke, Caiming Xu, Silvia Pascual-Sabater, Masanori Tokunaga, Tetsuji Takayama, Haiyong Han, Cristina Fillat, Yusuke Kinugasa, and Ajay Goel. 2023. "Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma" Biomedicines 11, no. 1: 119. https://doi.org/10.3390/biomedicines11010119

Okuno, K., Xu, C., Pascual-Sabater, S., Tokunaga, M., Takayama, T., Han, H., Fillat, C., Kinugasa, Y., & Goel, A. (2023). Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines, 11(1), 119. https://doi.org/10.3390/biomedicines11010119